Neonci Technologies
Tracked across 2 events · 12 articles · First seen Apr 07, 2026 · Last active Jun 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Neonci Technologies has gained increased visibility and investor confidence due to new analyst coverage, significant insider buying, and expanding institutional ownership, ahead of key clinical trial milestones for its brain cancer therapies.
May 19, 2026 · 6 articles
Regulatory
Impact: Neonci Technologies received IND authorization for NEO212 from the United Arab Emirates — Department of Health – Abu Dhabi, marking its first international regulatory clearance. This approval creates an additional clinical development pathway outside the United States and is a significant milestone for the company's neuro-oncology programs.
Jun 16, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Neonci Technologies live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard